pneumo 23 inj.sol 0,025mgx23/0,5ml
ΕΛΛΗΝΙΚΟ ΙΝΣΤΙΤΟΥΤΟ ΠΑΣΤΕΡ Βασ.Σοφίας 127,, 115 21 115 21, Αθήνα 6462281, 6430044 - purified capsular polysaccharides of streptococcus pneumoniae 23 - valent - inj.sol (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 0,025mgx23/0,5ml - purified capsular polysaccharides of streptococcus pneumoniae 23 - valent - pneumococcus, purified polysaccharides antigen
pneumo- 25mcgx23/0,5mlpfs ενεσιμο διαλυμα
sanofi pasteur europe, france - ΚΑΘΑΡΙΣΜΕΝΑ ΚΑΨΟΥΛΙΚΑ ΠΟΛΥΣΑΚΧΑΡΙΔΙΑ ΤΟΥ streptococcus pneumoniae 23 - valent - ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ - 25mcgx23/0,5mlpfs - ineof01224 - purified capsular polysaccharides of streptococcus pneumoniae 23 - valent - 0.030000 mg - pneumococcus, purified polysaccharides antigen
vaxneuvance
merck sharp & dohme b.v. - pneumococcal polysaccharide conjugate vaccine (adsorbed) - Πνευμονιοκοκκικές λοιμώξεις - pneumococcus, purified polysaccharides antigen conjugated - vaxneuvance is indicated for active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age. vaxneuvance is indicated for active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. Βλ. Ενότητες 4. 4 και 5. 1 για πληροφορίες σχετικά με την προστασία από συγκεκριμένους πνευμονοκοκκικούς ορότυπους. the use of vaxneuvance should be in accordance with official recommendations.
revaxis 0,5ml ενεσιμο εναιωρημα
sanofi pasteur europe, france (0000011723) 14 espace henry vallee, lyon, 69007 - purified diphteria toxoid; purified tetanus toxoid; inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii; aluminium hydroxide - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - 0,5ml - ineof00246 purified diphteria toxoid 2.000000 iu; ineof00247 purified tetanus toxoid 20.000000 iu; ineof00249 inactivated poliovirus vacc type i 40.000000; ineof00250 inactivated poliovirus vacc type ii 8.000000; ineof00251 inactivated poliovirus vacc type iii 32.000000; 0021645512 aluminium hydroxide 0.350000 mg - diphtheria-poliomyelitis-tetanus
equip-ft ενεσιμο εναιωρημα
pfizer ΕΛΛΑΣ Α.Ε. (0000000047) Μεσογείων 243,,154 51,154 51, Νέο Ψυχικό,gr - immunopurified ΤΟΞΟΕΙΔΈΣ ΤΟΥ ΤΕΤΆΝΟΥ, ΈΝΑ/ΙΣΟ/1/kentucky 98 * a/ΙΣΟ/2/ΒΟΡΛΑΝΓΕ 91 * a/ΙΣΟ/1/newmarket 77; haemaglutinin ΑΠΌ ΙΌ ΤΗΣ ΓΡΊΠΗΣ ΤΩΝ ΙΠΠΟΕΙΔΏΝ (ΑΔΡΑΝΟΠΟΙΗΜΈΝΟ) - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - immunopurified tetanus toxoid 0,00 inj.susp 0; a/equi/1/kentucky 98 0,00 inj.susp 0; a/equi/2/borlange 91 0,00 inj.susp 0; a/equi/1/newmarket 77 0,00 inj.susp 0; haemaglutinin of equine influenza virus (inactivated) 0,00 inj.susp 0 - immunologicals - Άλογα - Χρόνοι αναμονής: Άλογα
equip-t 100 lf units ενεσιμο εναιωρημα
pfizer ΕΛΛΑΣ Α.Ε. (0000000047) Μεσογείων 243,,154 51,154 51, Νέο Ψυχικό,gr - immunopurified ΤΟΞΟΕΙΔΈΣ ΤΟΥ ΤΕΤΆΝΟΥ - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - 100 lf units - immunopurified tetanus toxoid 100,00 inj.susp 100 lf units - vidarabine - Άλογα - Χρόνοι αναμονής: Άλογα
pentavac (εμβολιο) inj.susp 0,5ml (1dose)
sanofi pasteur europe, france 14 espace henry vallee, 69007 lyon +33 437 28 40 00 - purified tetanus toxoid; purified diphteria toxoid; purified pertussis toxoid (pt xd); filamentous haemagglutinin (fha); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii; haemophilus type b polysac. conjugated to tetanus protein - inj.susp (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ); pd.inj.sus (ΚΟΝΙΣ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - 0,5ml (1dose) - purified tetanus toxoid 40iu; purified diphteria toxoid 20iu; purified pertussis toxoid (pt xd) 25mcg; filamentous haemagglutinin (fha) 25mcg; inactivated poliovirus vacc type i 29u; inactivated poliovirus vacc type ii 7u; inactivated poliovirus vacc type iii 26u; haemophilus type b polysac. conjugated to tetanus protein 10mcg - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus
diftavax inj.susp (4+40)iu
vianex a.e. Οδός Τατοίου, 146 71 Ν. Ερυθραία 210-8009111 - purified diphteria toxoid; purified tetanus toxoid - inj.susp (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - (4+40)iu - purified diphteria toxoid; purified tetanus toxoid
διφθεριτικο-τετανικο-κοκκυτικο προσροφημενο(dtc) inj.susp
ΕΛΛΗΝΙΚΟ ΙΝΣΤΙΤΟΥΤΟ ΠΑΣΤΕΡ Βασ.Σοφίας 127,, 115 21 115 21, Αθήνα 6462281, 6430044 - purified diphteria toxoid; purified tetanus toxoid; bordetella pertussis - inj.susp (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - purified diphteria toxoid 30iu; purified tetanus toxoid 60iu; bordetella pertussis 4iu - pertussis, inactivated, whole cell, combinations with toxoids
tetravac inj.susp (1 dose) 0,5ml pf.syr
ΕΛΛΗΝΙΚΟ ΙΝΣΤΙΤΟΥΤΟ ΠΑΣΤΕΡ Βασ.Σοφίας 127,, 115 21 115 21, Αθήνα 6462281, 6430044 - purified diphteria toxoid; purified tetanus toxoid; purified pertussis toxoid (pt xd); filamentous haemagglutinin (fha); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii - inj.susp (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - (1 dose) 0,5ml pf.syr - purified diphteria toxoid; purified tetanus toxoid; purified pertussis toxoid (pt xd); filamentous haemagglutinin (fha); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii - diphtheria-pertussis-poliomyelitis-tetanus